These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 981705)

  • 41. Effects of acetylsalicylic acid and prostaglandin on endotoxin-induced pulmonary platelet sequestration.
    Thörnee LJ; Kuenzig M; Thörne LJ
    Acta Chir Scand; 1981; 147(3):161-2. PubMed ID: 7199241
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A role for prostaglandins and thromboxanes in the exposure of platelet fibrinogen receptors.
    Bennett JS; Vilaire G; Burch JW
    J Clin Invest; 1981 Oct; 68(4):981-7. PubMed ID: 6270196
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Arachidonic acid induces human platelet-fibrin retraction: the role of platelet cyclic endoperoxides.
    Di Minno G; Bertelé V; Cerletti C; de Gaetano G; Silver MJ
    Thromb Res; 1982 Feb; 25(4):299-306. PubMed ID: 6803385
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Inhibition of platelet prostaglandin synthetase by oral aspirin.
    Burch JW; Stanford N; Majerus PW
    J Clin Invest; 1978 Feb; 61(2):314-9. PubMed ID: 413839
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Lack of platelet effect with the aspirin analog, salsalate.
    Estes D; Kaplan K
    Arthritis Rheum; 1980 Nov; 23(11):1303-7. PubMed ID: 7447965
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Evidence that the rat is not an appropriate model to study the role of prostaglandins in normal or abnormal platelet aggregation.
    Huzoor-Akbar ; Anwer K
    Thromb Res; 1986 Feb; 41(4):555-66. PubMed ID: 3961734
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The influence of prostaglandin G2 on platelet ultrastructure and platelet secretion.
    Gerrard JM; Townsend D; Stoddard S; Witkop CJ; White JG
    Am J Pathol; 1977 Jan; 86(1):99-116. PubMed ID: 188341
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Unidirectional transfer of prostaglandin endoperoxides between platelets and endothelial cells.
    Schafer AI; Crawford DD; Gimbrone MA
    J Clin Invest; 1984 Apr; 73(4):1105-12. PubMed ID: 6423665
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Triggering by Paf-acether and adrenaline of cyclo-oxygenase-independent platelet aggregation.
    Fouque F; Vargaftig BB
    Br J Pharmacol; 1984 Nov; 83(3):625-33. PubMed ID: 6439269
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Oxygen consumption of human blood platelets. II. Effect of inhibitors on thrombin-induced oxygen burst.
    Muenzer J; Weinbach EC; Wolfe SM
    Biochim Biophys Acta; 1975 Feb; 376(2):243-8. PubMed ID: 1115776
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Platelet dysfunction in myeloproliferative syndromes.
    Phadke K; Dean S; Pitney WR
    Am J Hematol; 1981; 10(1):57-64. PubMed ID: 7258182
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The inhibitory effect of aspirin on platelet and vascular prostaglandins in rats cannot be completely dissociated.
    Villa S; Livio M; de Gaetano G
    Br J Haematol; 1979 Jul; 42(3):425-31. PubMed ID: 383131
    [No Abstract]   [Full Text] [Related]  

  • 53. Prothrombotic effects of erythrocytes on platelet reactivity. Reduction by aspirin.
    Santos MT; Valles J; Aznar J; Marcus AJ; Broekman MJ; Safier LB
    Circulation; 1997 Jan; 95(1):63-8. PubMed ID: 8994418
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The mechanism of the effect of aspirin on human platelets. I. Acetylation of a particulate fraction protein.
    Roth GJ; Majerus PW
    J Clin Invest; 1975 Sep; 56(3):624-32. PubMed ID: 1159076
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Functional and biochemical evaluation of platelet aspirin resistance after coronary artery bypass surgery.
    Zimmermann N; Wenk A; Kim U; Kienzle P; Weber AA; Gams E; Schrör K; Hohlfeld T
    Circulation; 2003 Aug; 108(5):542-7. PubMed ID: 12874188
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Transdermal modification of platelet function. A dermal aspirin preparation selectively inhibits platelet cyclooxygenase and preserves prostacyclin biosynthesis.
    Keimowitz RM; Pulvermacher G; Mayo G; Fitzgerald DJ
    Circulation; 1993 Aug; 88(2):556-61. PubMed ID: 8339418
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effect of oral aspirin dose on platelet aggregation and vascular prostacyclin (PGI2) synthesis in humans and rabbits.
    Ellis EF; Wright KF; Jones PS; Richardson DW; Ellis CK
    J Cardiovasc Pharmacol; 1980; 2(4):387-97. PubMed ID: 6156337
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Is platelet phospholipid-dependent thrombin generation altered by acute myocardial infarction or aspirin?
    Rota S; Flynn PD; Wareham NJ; Baglin TP; Byrne CD
    Thromb Res; 1996 Aug; 83(4):329-38. PubMed ID: 8870177
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cyclic adenosine 3',5'-monophosphate inhibits the availability of arachidonate to prostaglandin synthetase in human platelet suspensions.
    Minkes M; Stanford N; Chi MM; Roth GJ; Raz A; Needleman P; Majerus PW
    J Clin Invest; 1977 Mar; 59(3):449-54. PubMed ID: 190267
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Salicylate interferes in vivo with aspirin-induced inhibition of platelet and vascular prostaglandin generation in rats.
    Cerletti C; Livio M; de Castellarnau C; Dejana E; de Gaetano G
    Prostaglandins Leukot Med; 1982 Mar; 8(3):263-4. PubMed ID: 6952291
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.